| Long-Term Use of Bone Drugs May Be Linked to Esophageal
Cancer
(HealthDay) |
HealthDay - THURSDAY, Sept. 2 (HealthDay News) -- People with osteoporosis who take
drugs such as Boniva (ibandronate), Fosamax (alendronate) or Actonel
(risedronate) to strengthen their bones may be at an increased risk of
esophageal cancer, British researchers report. |
|
| Common bone drugs linked to esophageal cancer risk
(Reuters) |
Reuters - People who take a commonly used class of osteoporosis drugs called bisphosphonates for more than five years may be doubling their risk of developing cancer of the gullet or esophagus, a British study found on Friday. |
|
| Bone drugs may raise risk of throat cancer
(AP) |
AP - People who take bone-strengthening drugs for several years may have a slightly higher risk of esophageal cancer, a new study suggests. |
|
| Diabetes Drug Metformin Linked to Lower Lung Cancer Rate in
Mice
(HealthDay) |
HealthDay - WEDNESDAY, Sept. 1 (HealthDay News) -- A drug widely used to
treat high blood sugar in type 2 diabetics may hold some promise in the
prevention of tobacco-induced lung cancer, according to extremely
preliminary findings in a mouse study. |
|
| Diabetes drug may keep lung cancer at bay
(Reuters) |
 Reuters - The common diabetes drug metformin may hold promise as a way to keep smokers from developing lung cancer, U.S. researchers said on Wednesday.
|
|
| Diabetes drug fights lung cancer in mice: study
(AFP) |
 AFP - A popular drug that is used by millions of diabetics around the world significantly decreases tobacco-induced lung tumors in mice, a study published Wednesday found.
|
|
| Surgery prevents breast cancers in high-risk women
(Reuters) |
 Reuters - Women with mutations in the well-known BRCA1 or BRCA2 genes who have their breasts and ovaries removed are much more likely to survive than women who do not get preventive surgery, U.S. researchers said on Tuesday.
|
|
| CORRECTED: Surgery prevents breast cancers in high-risk women
(Reuters) |
Reuters - Women with mutations in the well-known BRCA1 or BRCA2 genes who have their breasts and ovaries removed are much more likely to survive than women who do not get preventive surgery, U.S. researchers said on Tuesday. |
|
| Cancer drug points way to new Alzheimer's approach
(Reuters) |
Reuters - An altered version of the cancer drug Gleevec could form the basis of a new class of drugs that block the development of brain-damaging plaques in Alzheimer's disease, U.S. researchers said on Wednesday. |
|
| No risk seen from delaying prostate cancer surgery
(Reuters) |
Reuters - Adding to evidence that men with early prostate cancer can safely put off surgery, a new study finds that patients who delayed surgery by over a year had similar outcomes as those who opted for immediate treatment. |
|
| Famed Tasmanian devil euthanized after tumor found
(AP) |
 AP - A Tasmanian devil named Cedric, once thought to be immune to a contagious facial cancer threatening the iconic creatures with extinction, has been euthanized after succumbing to the disease, researchers said Wednesday.
|
|
| Review Finds No Statin-Cancer Link
(HealthDay) |
HealthDay - TUESDAY, Aug. 31 (HealthDay News) -- There's no evidence that
popular cholesterol-lowering statins cause cancer, says a review that
challenges earlier research raising concerns that the drugs may be
associated with an increase in cancer and cancer-related deaths. |
|
